Patents by Inventor Denis Portnoi

Denis Portnoi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7601350
    Abstract: Purified antibodies that bind to M. tuberculosis ERP protein are disclosed. In one embodiment, a purified antibody, which binds specifically with a polypeptide comprising SEQ ID NO: 39 or SEQ ID NO: 41 is provided. In some embodiments the polypeptide has a theoretical molecular weight of about 28 kDa. In other embodiments the polypeptide has an observed molecular weight of about 36 kDa, as determined by denaturing polyacrylamide gel electrophoresis (SDS-PAGE). The purified antibody may be a monoclonal or a polyclonal antibody. Further embodiments provide antibodies that does not bind specifically with M. leprae P28 protein. The antibodies of the invention have many uses including the identification of M. tuberculosis.
    Type: Grant
    Filed: January 15, 2003
    Date of Patent: October 13, 2009
    Assignee: Institut Pasteur
    Inventors: Brigitte Gicquel, Eng Mong Lim, Denis Portnoi, Francois-Xavier Berthet, Juliano Timm
  • Patent number: 7244613
    Abstract: The invention concerns recombinant vectors replicated in mycobacteria, a set of sequences coding for exported polypeptides detected by fusion with alkaline phosphatase, in particular one polypeptide, called DP428, of about 12 kD corresponding to an exported protein found in mycobacteria belonging to the Mycobacterium tuberculosis complex. The invention also concerns methods and kits for detecting in vitro the presence of a mycobacterium and in particular a mycobacterium belonging to the Mycobacterium tuberculosis complex in a biological sample using said polypeptides, their fragments or polynucleotides coding for the latter. The invention also concerns immunogenic or vaccine compositions for preventing and/or treating infections caused by mycobacteria and in particular a mycobacterium belonging to said complex, particularly tuberculosis.
    Type: Grant
    Filed: May 16, 2001
    Date of Patent: July 17, 2007
    Assignee: Institut Pasteur
    Inventors: Brigitte Gicquel, Denis Portnoï, Eng-Mong Lim, Vladimir Pelicic, Agnès Guigueno, Yves Goguet De La Salmoniere
  • Publication number: 20070015173
    Abstract: Purified polynucleotides and polypeptides, and cells of M. smegmatis, M. bovis, M. bovis BCG, or M. africanum are provided.
    Type: Application
    Filed: January 11, 2006
    Publication date: January 18, 2007
    Inventors: Brigitte Gicquel, Denis Portnoi, Eng-Mong Lim, Vladimir Pelicic, Agnes Guigueno, Yves Goguet De La Salmoniere
  • Publication number: 20060127959
    Abstract: Purified antibodies that bind to M. tuberculosis ERP protein are disclosed. In one a embodiment, a purified antibody, which binds specifically with a polypeptide comprising SEQ ID NO: 39 or SEQ ID NO: 41 is provided. In some embodiments the polypeptide has a theoretical molecular weight of about 28 kDa. In other embodiments the polypeptide has an observed molecular weight of about 36 kDa, as determined by denaturing polyacrylamide gel electrophoresis (SDS-PAGE). The purified antibody may be a monoclonal or a polyclonal antibody. Further embodiments provide antibodies that does not bind specifically with M. teprae P28 protein. The antibodies of the invention have many uses including the identification of M. tuberculosis.
    Type: Application
    Filed: January 15, 2003
    Publication date: June 15, 2006
    Applicant: Institut Pasteur
    Inventors: Brigitte Gicquel, Eng Lim, Denis Portnoi, Francois-Xavier Berthet, Juliano Timm
  • Publication number: 20050158714
    Abstract: The invention concerns recombinant vectors replicated in mycobacteria, a set of sequences coding for exported polypeptides detected by fusion with alkaline phosphatase, in particular one polypeptide, called DP428, of about 12 kD corresponding to an exported protein found in mycobacteria belonging to the Mycobacterium tuberculosis complex. The invention also concerns methods and kits for detecting in vitro the presence of a mycobacterium and in particular a mycobacterium belonging to the Mycobacterium tuberculosis complex in a biological sample using said polypeptides, their fragments or polynucleotides coding for the latter. The invention also concerns immunogenic or vaccine compositions for preventing and/or treating infections caused by mycobacteria and in particular a mycobacterium belonging to said complex, particularly tuberculosis.
    Type: Application
    Filed: May 16, 2001
    Publication date: July 21, 2005
    Inventors: Brigitte Gicquel, Denis Portnoi, Eng-Mong Lim, Vladimir Pelicic, Agnes Guigueno, Yves Goguet De La Salmoniere
  • Publication number: 20040214165
    Abstract: The invention concerns recombinant vectors replicated in mycobacteria, a set of sequences coding for exported polypeptides detected by fusion with alkaline phosphatase, in particular one polypeptide, called DP428, of about 12 kD corresponding to an exported protein found in mycobacteria belonging to the Mycobacterium tuberculosis complex. The invention also concerns methods and kits for detecting in vitro the presence of a mycobacterium and in particular a mycobacterium belonging to the Mycobacterium tuberculosis complex in a biological sample using said polypeptides, their fragments or polynucleotides coding for the latter. The invention also concerns immunogenic or vaccine compositions for preventing and/or treating infections caused by mycobacteria and in particular a mycobacterium belonging to said complex, particularly tuberculosis.
    Type: Application
    Filed: May 16, 2001
    Publication date: October 28, 2004
    Inventors: Brigitte Gicquel, Denis Portnoi, Eng-Mong Lim, Vladimir Pelicic, Agnes Guigueno, Yves Goguet De La Salmoniere
  • Patent number: 6565855
    Abstract: Recombinant screening, cloning and/or expression vector characterized in that it replicates in mycobacteria and contains: 1) a mycobacteria functional replicon, 2) a selection marker, 3) a reporter cassette comprising: a) a multiple cloning site (polylinker), b) a transcription terminator which is active in mycobacteria and is located upstream of the polylinker, and c) a coding nucleotide sequence derived from a gene coding for an expression, export and/or secretion protein marker, the nucleotide sequence being deprived of its initiation codon and its regulating sequences. This vector is used for identification and expression of exporter polypeptides, such as the Mycobacterium tuberculosis P28 antigen.
    Type: Grant
    Filed: May 26, 2000
    Date of Patent: May 20, 2003
    Assignee: Institut Pasteur
    Inventors: Brigitte Gicquel, Eng Mong Lim, Denis Portnoi, Francois-Xavier Berthet, Juliano Timm
  • Patent number: 6248581
    Abstract: Recombinant screening, cloning and/or expression vector characterized in that it replicates in mycobacteria and contains 1) a mycobacteria functional replicon; 2) a selection marker, 3) a reporter cassette comprising a) a multiple cloning site (polylinker) b) a transcription terminator which is active in mycobacteria and is located upstream of the polylinker, and c) a coding nucleotide sequence derived from a gene coding for an expression, export and/or secretion protein marker, the nucleotide sequence being deprived of its initiation codon and its regulating sequences. This vector is used for identification and expression of exporter polypeptides, such as the Mycobacterium tuberculosis P28 antigen.
    Type: Grant
    Filed: June 9, 1997
    Date of Patent: June 19, 2001
    Assignee: Institut Pasteur
    Inventors: Brigitte Gicquel, Eng Mong Lim, Denis Portnoi, Francois-Xavier Berthet, Juliano Timm